News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

This Cheap Michigan Biotech Could Have Major Phase II Catalysts Coming



3/20/2017 7:13:44 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Shares have traded relatively flat since the company's initial public offering.

Share price could runup into three data readouts from phase 2b trials.

Principal asset gemcabene appears to have a differentiated profile that could allow the company to carve its niche in several indications in the cardiometabolic arena.

Read at Seeking Alpha


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES